NHS National Generics Pharmaceuticals Transition 2023_1
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £1
- Sector
- HEALTH
- Published
- 24 May 2023
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
United Kingdom:
1 buyer
- NHS England Leeds
31 suppliers
- Drreddys Laboratories Milton
- Milpharm South Ruislip
- Sandoz Camberley
- Teva Castleford
- Amarox Harrow
- Accord Devon
- Tillomed Laboratories Luton
- Wockhardt Wrexham
- Medac Pharma Stirling
- Sun Pharma Uxbridge
- Consilient Health Richamond Uponthames
- Day Lewis Medical Croydon
- Waymade London
- Zentiva Pharma London
- Aristo Pharma Ely
- Eramol Sevenoaks
- Thornton & Ross Linthwaite
- Roma Pharmaceuticals Burton upon Trent
- Drugsrus Northwood
- Aventis Pharma Reading
- Fontus Health Walsall
- Ipca Laboratories Sunderland
- Relonchem Widnes
- Strandhaven Ilford
- Neuraxpharm Cardiff
- Syri Ruislip
- Crescent Pharma Basingstoke
- Brown & Burk Hounslow West
- Thornton & Ross Lynthwaite
- Resolution Chemicals London
- Thea Pharmaceuticals Newcastle under Lyme
Description
Framework agreement for NHS National Generics Pharmacuticals Transition 2023_1. Offer reference number CM/PHG/22/5666.Potential periods of call-offs under the framework agreement: CM/PHG/22/5666/00 – Transition Products:CESW- /08/2023 – 31/01/2024 (6 months) NWLN 01/08/2023 – 31/01/2025 (18 months)LSNE 01/08/2023 – 31/05/2024 (10 months) CM/PHG/22/5666/01 – Orals (plus non-parenteral) Products: All regions: 01/08/2023 to 31/05/2024 (10 Months)
Lot Division
1 | CM/PHG/22/5666/00 - Supplier offer confirmation (Check box) Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. CM/PHG/22/5666/00 – Transition Products:CESW 01/08/2023 |
2 | CM/PHG/22/5666/01 - Supplier offer confirmation (Check box) Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.CM/PHG/22/5666/00 – Transition Products:CESW 01/08/2023 – 31/01/2024 (6 months)NWLN 01/08/2023 … – 31/05/2024 (10 months)CM/PHG/22/5666/01 – Orals (plus non-parenteral) Products:All regions: 01/08/2023 to 31/05/2024 (10 Months) |
Award Detail
1 | Drreddys Laboratories (Milton)
|
2 | Milpharm (South Ruislip)
|
3 | Sandoz (Camberley)
|
4 | Teva (Castleford)
|
5 | Amarox (Harrow)
|
6 | Accord (Devon)
|
7 | Tillomed Laboratories (Luton)
|
8 | Wockhardt (Wrexham)
|
9 | Medac Pharma (Stirling)
|
10 | Sun Pharma (Uxbridge)
|
11 | Consilient Health (Richamond Uponthames)
|
12 | Day Lewis Medical (Croydon)
|
13 | Waymade (London)
|
14 | Zentiva Pharma (London)
|
15 | Aristo Pharma (Ely)
|
16 | Eramol (Sevenoaks)
|
17 | Thornton & Ross (Linthwaite)
|
18 | Roma Pharmaceuticals (Burton upon Trent)
|
19 | Drugsrus (Northwood)
|
20 | Aventis Pharma (Reading)
|
21 | Fontus Health (Walsall)
|
22 | Ipca Laboratories (Sunderland)
|
23 | Relonchem (Widnes)
|
24 | Milpharm (South Ruislip)
|
25 | Sandoz (Camberley)
|
26 | Teva (Castleford)
|
27 | Amarox (Harrow)
|
28 | Accord (Devon)
|
29 | Strandhaven (Ilford)
|
30 | Neuraxpharm (Cardiff)
|
31 | Syri (Ruislip)
|
32 | Crescent Pharma (Basingstoke)
|
33 | Brown & Burk (Hounslow West)
|
34 | Thornton & Ross (Lynthwaite)
|
35 | Resolution Chemicals (London)
|
36 | Drugsrus (Northwood)
|
37 | Thea Pharmaceuticals (Newcastle under Lyme)
|
Renewal Options
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months
Award Criteria
price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-039687
- FTS 014809-2023